JESUS GUERRA: Open Payments
NPI 1558610477 · WESLACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 29 payments from 12 companies in 2025. Trend: 2023 $477 · 2024 $676 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $113 |
| Novo Nordisk Inc | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Abbott Laboratories | 2 | $34 |
| Phadia US Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, Kerendia, FARXIGA, TRELEGY ELLIPTA, JARDIANCE, Rybelsus, Wegovy, KISUNLA.
Industry payments across TX — which companies pay providers there.
